Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes

Inclusion Criteria: * Type 1 diabetes for at least 1 year * HbA1c below 12.0% * Treatment with regular human insulin and insulin NPH for at least 1 month * Receive more than 2 injections daily Exclusion Criteria: * Receipt of investigational product within 6 months prior to trial participation * Known or suspected allergy to investigational product * Receipt of of insulin aspart within 3 months prior to trial participation